Events & Presentations


Bristol-Myers Squibb Conference Call on the Mead Johnson Split-Off
Monday, November 16, 2009 8:30 a.m. ET  
Webcast Presentation
Click here for webcast

Event Details
TitleBristol-Myers Squibb Conference Call on the Mead Johnson Split-Off
Date and TimeMonday, November 16, 2009 8:30 a.m. ET  
Additional InformationIn connection with the proposed disposition by Bristol-Myers Squibb of its interest in Mead Johnson via an exchange offer, Mead Johnson has filed with the Securities and Exchange Commission a registration statement that includes an exchange offer prospectus. Investors and security holders are urged to read carefully and in its entirety the prospectus, and any other relevant documents filed with the SEC, before making any investment decision. You can obtain a free copy of the prospectus and other related documents filed with the SEC by Bristol-Myers Squibb or Mead Johnson at the SEC’s web site at www.sec.gov. The prospectus may also be obtained for free from Mead Johnson at www.mjn.com.

This communication is for informational purposes only and is neither an offer to sell nor an offer to buy any securities or a recommendation as to whether you should participate in the exchange offer. The offer is made solely by the prospectus.

Materials on this website may contain information about the Company’s future plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Forward-looking statements contained on this website should be evaluated together with the many uncertainties that affect Bristol-Myers Squibb's business, particularly those identified in the cautionary factors discussion in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. These documents are available from the Securities and Exchange Commission, the Bristol-Myers Squibb website or from Bristol-Myers Squibb Investor Relations.

In addition, any information contained on this website was current as of the date presented and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change, whether as a result of new information, future events or otherwise. Consequently, the company will not update the information contained on the website and investors should not rely upon the information as current or accurate after the presentation date. The website may also contain certain non-GAAP financial measures, adjusted to include certain costs, expenses, gains and losses and other specified items. Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures for a particular quarterly period are available on the company’s website at www.bms.com.